Studies of microRNAs as potential targets of treatments for viral infection have shown that miR-1290 is upregulated in SARS-CoV-2 infection, and this is predicted to result in downregulation of NRXN1 expression (Chen and Wang, 2020; Guterres et al., 2020). Here, NRXN1 is linked to viral infectious disease.